Clinical Trial Update: A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating intrathecal SHP611 in children with Metachromatic Leukodystrophy; results have been posted and the trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metachromatic Leukodystrophy

Drugs mentioned

• SHP611

Snippet

Sponsor: Shire | Conditions: Metachromatic Leukodystrophy (MLD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-06-06